A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation

Journal: Nature Communications

Published: 2020-05-08

DOI: 10.1038/s41467-020-16038-6

Affiliations: 14

Authors: 19

Go to article
Institutions Share
Division of Cardiovascular Medicine, UMass Medical School, United States of America (USA) 0.18
State Key Laboratory of Cellular Stress Biology, XMU, China 0.11
Department of Pathology and Laboratory Medicine, Cornell University, United States of America (USA) 0.11
Division of Cardiovascular Medicine, BWH, United States of America (USA) 0.11
Institute for Cancer Genetics (ICG), CU, United States of America (USA) 0.08
College of Medicine (YUCM), Yonsei University, South Korea 0.05
Department of Integrative Biotechnology, SKKU, South Korea 0.05
KAIST Department of Mathematical Sciences, South Korea 0.05
Brigham and Women's Hospital (BWH), United States of America (USA) 0.05
Cancer Biology and Infection Laboratory (BCI), France 0.05
KinaseDetect ApS, Denmark 0.05
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan 0.05
Department of Pathology and Cell Biology, CU, United States of America (USA) 0.03
Li Weibo Institute for Rare Diseases Research, UMass Medical School, United States of America (USA) 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER